Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.
Press releases published on August 11, 2025
Altimmune Board of Directors Appoints Jerry Durso as Chairman
GlobeNewswire
·
August 11, 2025
Appointment recognizes Mr. Durso’s extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH Mitchel Sayare, Ph.D., to remain on the Board as Independent Director GAITHERSBURG, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) …
Avicanna Announces US Patent and Trademark Office Issuance of New Patent
GlobeNewswire
·
August 11, 2025
USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on …
MAX Power Partners with Caram Media and TMI Digital to Drive Strategic Marketing and Spotlight Natural Hydrogen Story
GlobeNewswire
·
August 11, 2025
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) (“MAX Power” or the “Company”) is pleased to announce strategic partnerships with Caram Media Inc. (“Caram”) and TMI Digital (“TMI …
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
GlobeNewswire
·
August 11, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its second quarter 2025 financial …
Lithium Argentina Reports Second Quarter 2025 Results
GlobeNewswire
·
August 11, 2025
ZUG, Switzerland, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) today announced its second quarter 2025 results. Unless otherwise stated, results are presented in United States dollar. …
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
GlobeNewswire
·
August 11, 2025
JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today its intention to offer $400.0 million aggregate principal amount of convertible senior notes due 2030 (the “notes”) in a private …
BioCryst Announces Departure of Dr. Helen Thackray
GlobeNewswire
·
August 11, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that Dr. Helen Thackray, chief research and development officer, will leave the company September 1, 2025 and transition into an …
American Tungsten Provides Update on Site Rehabilitation Progress and Federal Engagement
GlobeNewswire
·
August 11, 2025
Vancouver, BC, Aug. 11, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) American Tungsten is pleased to provide an operational update on the ongoing production-readiness efforts at …
NorthWest Closes Second Tranche of Flow Through Financing and Completes Hard Dollar Placement
GlobeNewswire
·
August 11, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- NorthWest Copper Corp. (“NorthWest” or “the Company”) (TSX-V: NWST) is pleased to announce that further to its …
LYNO AI Hits Key Milestone in Early Presale with 176K Tokens Sold at Launch Price
GlobeNewswire
·
August 11, 2025
ROAD TOWN, British Virgin Islands, Aug. 11, 2025 (GLOBE NEWSWIRE) -- LYNO AI is experiencing a major breakthrough as it reaches a critical point in its presale campaign, in which 176,503.21 tokens are sold at a launching price of 0.050 dollars each. Such a …
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
GlobeNewswire
·
August 11, 2025
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Podle průzkumu kryptoburzy Bitget mají Evropané navzdory současným překážkám obrovský zájem o placení kryptoměnami na dovolené
GlobeNewswire
·
August 11, 2025
VICTORIA, Seychely, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Bitget, přední kryptoměnová burza a společnost Web3, zveřejnila závěry svého nejnovějšího průzkumu. Byl zaměřen na preference a omezení, se kterými se více než 3000 evropských uživatelů kryptoměn …